Will the new Omicron sub-variant in B.C. cause another wave of infections? An expert weighs in

66 cases have been identified in the province so far and experts fear it is more transmissible than the original strain.

A new sub-lineage of the Omicron coronavirus variant is spreading across Europe at a concerning rate and 66 cases have been identified so far in B.C.

Scientists and health officials around the world are keeping their eyes on the descendant of the highly-transmissible variant that has been found in at least 40 countries. 

Known as BA.2, scientists widely consider it to be stealthier than the original version of omicron because particular genetic traits make it somewhat harder to detect. Others worry it could also be more contagious.

In an emailed statement, the B.C. Ministry of Health told Vancouver Is Awesome that “BA.1 and BA.2 share many of the same mutations, but there are also mutations that are specific to each lineage.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below